drugset / Trial / NCT05389267
Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.
RandomizedParallel-groupDouble-blindTreatment
Summary
The study purpose is to evaluate the safety of T4090.
Timeline
- Start
- 2022-07-05
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Kinezodianone R hydrochloride | Unknown | — | Other |